NCT00029913 - A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

HIV Infections

Interventions

OTHER

Observation

Observation of participants who received HIV preventive vaccine and became infected.

Trial Locations (21)

2013

Perinatal HIV Research Unit, Chris Hani Baragwanat, Bertsham

7705

University of Cape Town. Institute of Infectious Diseases, Mowbray

10003

New York Blood Ctr / Union Square, New York

10032

Columbia Univ, New York

14642

Univ of Rochester Med Ctr, Rochester

21201

University of MD - Inst. of Human Virology (IHV), Baltimore

21205

Jhu-Cir/Dc, Baltimore

Johns Hopkins Univ, Baltimore

35294

Univ of Alabama at Birmingham, Birmingham

37232

Vanderbilt Univ Hosp, Nashville

63110

Saint Louis University School of Medicine, St Louis

94102

Mt Zion Hospital, San Francisco

San Francisco Dept of Hlth / AIDS Office, San Francisco

98109

Fred Hutchinson Cancer Research Ctr, Seattle

02115

Fenway Community Health, Boston

Harvard University / Brigham and Women's Hospital, Boston

02906

Miriam Hosp, Providence

20210-303

Hospital Escola Sao Francisco de Assis (HESFA), Cidade Nova

Unknown

Asociacion Civil Selva Amazonica, Iquitos

Impacta - Asociacion Civil Impacta Salud y Educaci, Lima

2571 SF

KOSH District HVTU, Klerksdorp

All Listed Sponsors

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

HIV Vaccine Trials Network

NETWORK